Recent Advances in Luminescent Metallacycle/Metallacage for Biomedical Imaging and Cancer Therapy

Yida Pang,Chonglu Li,Hongping Deng,Yao Sun
DOI: https://doi.org/10.1039/d2dt02766f
IF: 4
2022-09-25
Dalton Transactions
Abstract:Small molecule metal-based drugs have made great achievements in preclinical and clinical applications. In particular, platinum based antitumor drugs have been well established in current cancer chemotherapy. However, it faces problems such as poor selectivity, large toxicity and side effects, strong drug resistance, poor uptake/retention in vivo, and difficulty in monitoring the therapeutic effect in real time, which largely limit their widespread use in clinical applications. The metallacycle/metallacage formed by the coordination-driven self-assembly of high-emitting ligands can solve the above problems. Importantly, acceptors with chemotherapeutic properties in the metallacycle/metallacage can be combined with luminescent ligands to achieve a combination of chemotherapy, imaging contrast agents and multifunctional therapeutic platforms. Here, this review provides an insight of the paradigm of self-assembled metallacycle/metallacage in biological applications, from mono-chemotherapeutic drugs to excellent fluorescent imaging contrast agents and multifunctional therapeutic platforms.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?